| Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide CG Kanakry, S Ganguly, M Zahurak, J Bolaños-Meade, C Thoburn, ... Science translational medicine 5 (211), 211ra157-211ra157, 2013 | 363 | 2013 |
| Modern approaches to HLA-haploidentical blood or marrow transplantation CG Kanakry, EJ Fuchs, L Luznik Nature reviews Clinical oncology 13 (1), 10-24, 2016 | 356 | 2016 |
| Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide SR McCurdy, JA Kanakry, MM Showel, HL Tsai, J Bolaños-Meade, ... Blood, The Journal of the American Society of Hematology 125 (19), 3024-3031, 2015 | 304 | 2015 |
| Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using … CG Kanakry, PV O'Donnell, T Furlong, MJ De Lima, W Wei, M Medeot, ... Journal of Clinical Oncology 32 (31), 3497, 2014 | 275 | 2014 |
| Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis SA Buckley, BL Wood, M Othus, CS Hourigan, C Ustun, MA Linden, ... haematologica 102 (5), 865, 2017 | 256 | 2017 |
| Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression LP Wachsmuth, MT Patterson, MA Eckhaus, DJ Venzon, RE Gress, ... The Journal of clinical investigation 129 (6), 2357-2373, 2019 | 217 | 2019 |
| Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS CG Kanakry, HL Tsai, J Bolaños-Meade, BD Smith, I Gojo, JA Kanakry, ... Blood, The Journal of the American Society of Hematology 124 (25), 3817-3827, 2014 | 204 | 2014 |
| Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice S Ganguly, DB Ross, A Panoskaltsis-Mortari, CG Kanakry, BR Blazar, ... Blood, The Journal of the American Society of Hematology 124 (13), 2131-2141, 2014 | 203 | 2014 |
| Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide SR McCurdy, YL Kasamon, CG Kanakry, J Bolaños-Meade, HL Tsai, ... Haematologica 102 (2), 391, 2017 | 176 | 2017 |
| Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide CG Kanakry, DG Coffey, AMH Towlerton, A Vulic, BE Storer, J Chou, ... JCI insight 1 (5), 2016 | 131 | 2016 |
| Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host … JA Kanakry, YL Kasamon, J Bolaños-Meade, IM Borrello, RA Brodsky, ... Biology of Blood and Marrow Transplantation 19 (10), 1514-1517, 2013 | 115 | 2013 |
| HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis M Gooptu, R Romee, A St. Martin, M Arora, M Al Malki, JH Antin, ... Blood, The Journal of the American Society of Hematology 138 (3), 273-282, 2021 | 109 | 2021 |
| Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission A Rashidi, M Hamadani, MJ Zhang, HL Wang, H Abdel-Azim, M Aljurf, ... Blood advances 3 (12), 1826-1836, 2019 | 107 | 2019 |
| Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis SR Goldsmith, MB Abid, JJ Auletta, A Bashey, A Beitinjaneh, P Castillo, ... Blood, The Journal of the American Society of Hematology 137 (23), 3291-3305, 2021 | 106 | 2021 |
| Mechanisms of graft-versus-host disease prevention by post-transplantation cyclophosphamide: an evolving understanding NS Nunes, CG Kanakry Frontiers in immunology 10, 484414, 2019 | 93 | 2019 |
| Short telomere syndromes cause a primary T cell immunodeficiency CL Wagner, VS Hanumanthu, CC Talbot, RS Abraham, D Hamm, ... The Journal of clinical investigation 128 (12), 5222-5234, 2018 | 88 | 2018 |
| Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide CG Kanakry, J Bolaños-Meade, YL Kasamon, M Zahurak, N Durakovic, ... Blood, The Journal of the American Society of Hematology 129 (10), 1389-1393, 2017 | 79 | 2017 |
| Intravenous busulfan compared with total body irradiation pretransplant conditioning for adults with acute lymphoblastic leukemia P Kebriaei, C Anasetti, MJ Zhang, HL Wang, I Aldoss, M de Lima, ... Biology of blood and marrow transplantation 24 (4), 726-733, 2018 | 78 | 2018 |
| Neuregulin-1 regulates cell adhesion via an ErbB2/phosphoinositide-3 kinase/Akt-dependent pathway: potential implications for schizophrenia and cancer CG Kanakry, Z Li, Y Nakai, Y Sei, DR Weinberger PloS one 2 (12), e1369, 2007 | 75 | 2007 |
| Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells CG Kanakry, AD Hess, CD Gocke, C Thoburn, F Kos, C Meyer, J Briel, ... Blood, The Journal of the American Society of Hematology 117 (2), 608-617, 2011 | 72 | 2011 |
